Our Advantage

GE HealthCare’s comprehensive tools are designed to support you in achieving early detection, clinical and operational efficiency, and better health outcomes.

Theranostics

Cancer is personal. Treatment should be too. GE HealthCare’s complete portfolio of Theranostics-enabling solutions is designed specifically for this new era in cancer care.

With Theranostics, therapeutics and diagnostics are combined to deliver intelligently efficient, precise, personal care.

Radiation Oncology

Radiation oncology is a critical component of cancer management, fueled by rapid progress in the application of advanced imaging techniques, availability of functional information, and a more thorough understanding of cancer biology to enable

more precise and effective cancer therapies. GE HealthCare’s innovative multimodal radiation therapy solutions provide the imaging tools and support you need to improve patient-centered care and advance the practice of precision medicine.

One-Stop Breast Clinic

Waiting for answers after an abnormal mammogram can be anxiety-producing. The One-Stop Breast Clinic is designed to help alleviate some of that stress by shortening the time between exam, results, and treatment planning.

By completely re-engineering the breast health pathway, GE HealthCare has reduced the time from abnormal screening mammogram to diagnosis from weeks to days.

Service Solutions

Boost the impact of your teams, operations and care experience by collaborating with GE HealthCare Service Solutions. With flexible and vendor-agnostic service capabilities powered by remote, AI, and predictive services; digital service

management; over 4,000 service engineers and applications specialists; an extensive parts network; and 24/7 repair services, our holistic approach to service helps you optimize your assets, patient flow, and workforce.

Healthcare Financial Services

With more than 45 years of experience, we help customers improve their clinical, operational, and financial outcomes by providing flexible offerings to meet their cash and technology needs.

Healthcare Financial Services can help customers manage today’s industry dynamics while also planning for the future.

Explore our suite of product solutions for every phase of the care pathway.

Early Detection

Diagnosis

Treatment

Follow-Up

Footnotes

1. Gordon PB. The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening. Curr Oncol. 2022;29(5):3595-3636. Published 2022 May 17. doi:10.3390/curroncol29050291. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140155/
2. FDA PMA P110006 summary of safety and effectiveness. https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110006B.pdf
4. Henschke CI, et al., A 20-year follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Radiology 2023; DOI: 10.1148/radiol.231988.
5. Selove R, Kilbourne B, Fadden MK, et al. Time from Screening Mammography to Biopsy and from Biopsy to Breast Cancer Treatment among Black and White, Women Medicare Beneficiaries Not Participating in a Health Maintenance Organization. Women’s Health Issues. 2016;26(6):642-647. doi:10.1016/j.whi.2016.09.003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116399
6. Chang SB, et al. SS2-06. Characterization of breast cancer management during the COVID 19 pandemic in a large integrated healthcare delivery system: Stage at diagnosis and timing/modality of first treatment. Presented at: San Antonio Breast Cancer Symposium, 2020. https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1186409
7. Based on a simulated user evaluation of OncoFlow at a UK University hospital in a test environment with 15 external users familiar with cancer patient medical records (7 oncologist, 5 nurses, 2 practitioners, 1 MDT coordinator). Each participant completed a series of tasks using both their existing EMR system and OncoCare. Mouse clicks and time to perform each task were recorded. User experience feedback was collected with a survey questionnaire. The study was facilitated by a third-party consulting agency and sponsored by GE HealthCare. The results are not prescriptive and could vary depending on user, electronic patient medical records software used, and circumstances.
8. Global Oncology Trends 2019, IQVIA Institute, ©2019 IQVIA, May 2019. https://www.iqvia.com/insights/the-iqvia-institute/reports/global-oncology-trends-2019
9. MEDraysintell 2021; Marketed Radiopharmaceuticals Report & Directory – Edition 2021.
10. Schenkel C, Levit LA, Kirkwood MK, et al. The state of professional wellbeing and satisfaction among US oncologists. Presented at ASCO Quality Care Symposium 2023. October 27-28, 2023. Boston, Massachusetts. Abstract. https://meetings.asco.org/abstracts-presentations/228098

* Revolution™ is a trademark of GE HealthCare, One-Stop Clinic™ is a trademark of GE HealthCare
** **Optellum Virtual Nodule Clinic is a third-party application distributed by GE HealthCare. Optellum Virtual Nodule Clinic software has been trained using multiple databases of CT scans and eventual diagnoses from healthcare systems in the UK, US, and Europe.